International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1326-1334, 1 April 2009

Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging

  • Yan-Ping Mao, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Fang-Yun Xie, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Li-Zhi Liu, M.D.

      Affiliations

    • Imaging Diagnosis and Interventional Center, Cancer Center, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Ying Sun, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Li Li, M.D., Ph.D.

      Affiliations

    • Imaging Diagnosis and Interventional Center, Cancer Center, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Ling-Long Tang, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Xin-Biao Liao, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Hong-Yao Xu, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Lei Chen, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Shu-Zhen Lai, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Ai-Hua Lin, M.D., Ph.D.

      Affiliations

    • Department of Medical Statistics and Epidemiology, Sun Yat-sen University School of Public Health, Guangzhou, People's Republic of China
  • ,
  • Meng-Zhong Liu, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
  • ,
  • Jun Ma, M.D.

      Affiliations

    • Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou, People's Republic of China
    • Corresponding Author InformationReprint requests to: Jun Ma, M.D., Department of Radiation Oncology, State Ke Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, No. 651 Rd. Dong Feng E., Guangzhou, Guangdong 510060 People's Republic of China. Tel: (+86) 20-8734-3469; Fax: (+86) 20-8734-3295

Received 20 February 2008; received in revised form 30 June 2008; accepted 10 July 2008. published online 19 January 2009.

Purpose

To use magnetic resonance imaging to re-evaluate and improve the 6th edition of the International Union Against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma.

Methods and Materials

We performed a retrospective review of the data from 924 biopsy-proven nonmetastatic nasopharyngeal carcinoma cases. All patients had undergone magnetic resonance imaging examinations and received radiotherapy as their primary treatment.

Results

The T classification, N classification, and stage group were independent predictors. No significant differences in the local failure hazards between adjacent T categories were observed between Stage T2b and T1, Stage T2b and T2a, and Stage T2b and T3. Although the disease failure hazards for Stage T1 were similar to those for Stage T2a, those for Stage T2b were similar to those for Stage T3. Survival curves of the different T/N subsets showed a better segregation when Stage T2a was downstaged to T1, T2b and T3 were incorporated into T2, and the nodal greatest dimension was rejected. The disease failure hazard for T3N0-N1 subsets were similar to those of the T1-T2N1 subsets belonging to Stage II; the same result was found for the T4N0-N2 subsets in the sixth American Joint Committee on Cancer staging system. However, the staging system we propose shows more consistent hazards within the same stage group and better survival discrimination among T categories, N categories, and overall stages.

Conclusion

Using the 6th American Joint Committee on Cancer staging system produces an acceptable distribution of patient numbers and segregation of survival curves among the different stage groups. The prognostic accuracy of the staging system could be improved by recategorizing the T, N, and group stage criteria.

Nasopharyngeal carcinoma, Staging system, Prognostication, Magnetic resonance imaging, Proposed refinements

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from the National Natural Science Foundation of China (Grant 30470505), the Science Foundation from the Sci--Tech Office of Guangdong Province, China (Grant 2004B5050301005), and the Science Foundation of Key Hospital Clinical Program from the Ministry of Health of China (Grant 2007-353).

 Conflict of interest: none.

PII: S0360-3016(08)03352-X

doi:10.1016/j.ijrobp.2008.07.062

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1326-1334, 1 April 2009